OMICRON VARIANT UPDATE:
Two of the three monoclonal antibodies FDA-authorized for COVID-19 in the United States, REGEN-COV and bam/ete, are ineffective against the Omicron variant. As such, new shipments of REGEN-COV and bam/ete to Kentucky have ended as of January 3, 2022. The third FDA-authorized monoclonal antibody, sotrovimab, is available nationwide in only very limited quantities.
Unless sotrovimab supplies increase and/or new monoclonal antibodies effective against the Omicron variant are released, supplies in Kentucky will be extremely limited and many treatment locations will not have monoclonal antibodies to offer at their sites. We urge all eligible persons 5 and older to get vaccinated and/or boosted with a Moderna or Pfizer mRNA COVID-19 vaccine to prevent serious and/or life-threatening COVID-19 disease.
Source: Kentucky Public Health
St. Elizabeth Healthcare has been designated a Kentucky Regional COVID-19 Antibody Administration Center (CAAC) and has supplies of monoclonal antibody therapy, which has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
In published studies, monoclonal antibodies decrease a patient's viral load, which may reduce the possibility of disease progression and hospitalization.
To determine if you are a candidate for therapy, please contact your primary care provider.
St. Elizabeth - Crestview Hills
380 Centre View Boulevard
Crestview Hills, KY 41017
Sunday: 8 AM - 4 PM
Monday: 8 AM - 4 PM
Tuesday: 8 AM - 4 PM
Wednesday: 8 AM - 4 PM
Thursday: 8 AM - 4 PM
Friday: 8 AM - 4 PM
Saturday: 8 AM - 4 PM